1613220-01-1

Basic information

• Product Name: 6-(4-phenylthiazol-2-yl)-quinoline-3-carboxylic acid methyl ester
• Synonyms: 6-(4-phenylthiazol-2-yl)-quinoline-3-carboxylic acid methyl ester
• CAS NO: 1613220-01-1
• Molecular Weight: 346.409
• Mol File: 1613220-01-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6-(4-phenylthiazol-2-yl)-quinoline-3-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(4-phenylthiazol-2-yl)-quinoline-3-carboxylic acid methyl ester(1613220-01-1)
• EPA Substance Registry System: 6-(4-phenylthiazol-2-yl)-quinoline-3-carboxylic acid methyl ester(1613220-01-1)

Safety Data

• Hazardous Substances Data: 1613220-01-1(Hazardous Substances Data)

Upstream product

• 1220418-81-4 6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-quinoline-3-carboxylic acid methyl ester 
• 57516-16-2 2-bromo-4-phenyl-1,3-thiazole 
• 1220418-77-8 6-bromoquinoline-3-carboxylic acid methyl ester 
• 798545-30-9 6-bromoquinoline-3-carboxylic acid 

Relevant articles and documents

SUBSTITUTED THIAZOLE COMPOUNDS

The invention is concerned with the compounds of formula (I): and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are LMP7 inhibitors and may be useful in treating associated inflammatory diseases and disorders such as, for example, rheumatoid arthritis, lupus and irritable bowel disease.